BeiGene, Ltd. revenue for the last year amounted to 2.46 B USD, the most of which — 2.46 B USD — came from its highest performing source at the moment, Pharmaceutical Products, the year earlier bringing 1.42 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought BeiGene, Ltd. 1.13 B USD, and the year before that — 502.63 M USD.